Search Within

Chung-Han Lee

  1. "MSK Grad Students"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (11)
  2. GSK Faculty (11)
  3. Genitourinary Oncology Service (11)
  4. Human Oncology and Pathogenesis Program (11)
  5. MSK Grad Students (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Abraham Hakimi (7)
  2. Eduard Reznik (6)
  3. Martin Voss (5)
  4. Ritesh Kotecha (5)
  5. Robert Motzer (5)
  6. Angela Brannon (4)

More People

Years
  1. 2023 (3)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2016 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Cell Metabolism (1)
  5. Clinical Cancer Research (1)
  6. Frontiers in Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. American Society for Clinical Investigation (1)
  4. Cell Press (1)
  5. Elsevier Inc. (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
    Journal Article

    Tang, C.; Xie, A. X.; Liu, E. M.; Kuo, F.; Kim, M.; DiNatale, R. G.; Golkaram, M.; Chen, Y. B.; Gupta, S.; Motzer, R. J.; more...
    Cell Metabolism (2023)

    Fulltext@MSK | Save
  • Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer
    Meeting Abstract

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Chen, Z.; Lattanzi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
    Meeting Abstract

    Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Molecular characterization of the tumor microenvironment in renal medullary carcinoma
    Journal Article

    Tourigny, D. S.; Zucker, M.; Kim, M.; Russo, P.; Coleman, J.; Lee, C. H.; Carlo, M. I.; Chen, Y. B.; Hakimi, A. A.; Kotecha, R. R.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Lenis, A. T.; Chen, Z.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab
    Journal Article

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Valero, C.; Vuong, L.; Lee, M.; Weiss, K.; Hoen, D.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
    Journal Article

    Xu, J.; Pham, C. G.; Albanese, S. K.; Dong, Y.; Oyama, T.; Lee, C. H.; Rodrik-Outmezguine, V.; Yao, Z.; Han, S.; Chen, D.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save